UCL Cancer Institute


NIHR Blood and Transplant Research Unit - Stem Cells and Immunotherapies

Director: Professor Karl Peggs

National Institute for Health Research (NIHR) Blood and Transplant Research Units (BTRUs) are research partnerships between universities and NHS Blood and Transplant (NHSBT). Multidisciplinary centres of excellence, BTRUs support the needs NHSBT for research to improve the supply of blood, blood products, stem cells and tissues and organs for transplantation. 

The NIHR BTRU in Stem Cells and Immunotherapies is an inter-disciplinary partnership between University College London (UCL), King's College London, Queen Mary University of London and NHS Blood and Transplant. 

The aim of the unit is to translate scientific advances in epigenetic profiling, molecular engineering and cellular immunotherapies to optimise the selection of blood donors and to develop new and improved treatment opportunities relating to haematopoietic stem cell transplantation and immune therapies.

NIHR Blood and Transplant Research Unit on Stem Cells and Immunotherapy at University College London


Find out more about the basic science and translational research undertaken by the Unit within our four research themes.

Get involved

Would you like to get actively involved in healthcare research? Patient and public opinion is essential to our work.

News and events

Learn more about the latest news and upcoming events.


The BTRU in Stem Cells and Immunotherapies operates across multiple sites, co-ordinated at the UCL Cancer Institute.

UCL Cancer Institute
Paul O'Gorman Building
72 Huntley Street

Tel: +44 (0)20 7679 6500 (Reception)
Enquiries: ci.contact@ucl.ac.uk